Clinical trials recruiting in Yongin-si, South Korea

Phase breakdown

Conditions recruiting in Yongin-si, South Korea

Recruiting trials in Yongin-si, South Korea

• A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
  NCT06792695 · Phase: Phase 2 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
  NCT07083206 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female)
• Comparison of Functional Recovery After Total Knee Arthroplasty Between Low Phase Angle and High Phase Angle Group
  NCT06701474 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female)
• Comparison of Patient Understanding and Anxiety According to the Delivery Method of Educational Videos
  NCT07550686 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female)
• Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
  NCT06772168 · Phase: Phase 3 · Ages: 19 Years to 80 Years · Sex: All (male and female)
• In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
  NCT06493799 · Phase: Phase 3 · Ages: 19 Years to 70 Years · Sex: All (male and female)
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
  NCT07085767 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
  NCT06603558 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female)
• Prediction of Postoperative Outcomes After TKA Using Instrumented Insoles and DNN
  NCT07367789 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female)
• Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
  NCT05490433 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 70 Years · Sex: Female
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female)
• Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
  NCT07493304 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Yongin-si, South Korea?

14 recruiting trials have at least one study site in Yongin-si, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.